Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLRZ Polyrizon Ltd.

盘后交易 02-04 18:08:45 EST

13.37

-2.39

-15.16%

盘后13.27

-0.10-0.75%

17:56 EST

最高16.15	最低13.35	成交量12.64万
今开16.15	昨收15.76	日振幅17.77%
总市值1,393万	流通市值1,333万	总股本104.17万
成交额191.21万	换手率12.68%	流通股本99.68万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":13.37,"timestamp":1770238800000,"preClose":15.76,"halted":0,"volume":126397,"hourTrading":{"tag":"盘后","latestPrice":13.27,"preClose":13.37,"latestTime":"17:56 EST","volume":3034,"amount":40460.75652,"timestamp":1770245810391,"change":-0.1,"changeRate":-0.007479,"amplitude":0.05834},"delay":0,"changeRate":-0.15164974619289343,"floatShares":996800,"shares":1041700,"eps":-0.71144193,"marketStatus":"盘后交易","change":-2.39,"latestTime":"02-04 18:08:45 EST","open":16.15,"high":16.15,"low":13.35,"amount":1912087.428301,"amplitude":0.177665,"askPrice":13.98,"askSize":1,"bidPrice":13.1,"bidSize":22,"shortable":0,"etf":0,"ttmEps":-0.71144193,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770253200000},"marketStatusCode":4,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":15.76,"preHourTrading":{"tag":"盘前","latestPrice":16.15,"preClose":15.76,"latestTime":"09:25 EST","volume":11095,"amount":185589.19379,"timestamp":1770215145114,"change":0.39,"changeRate":0.024746,"amplitude":0.154822},"postHourTrading":{"tag":"盘后","latestPrice":13.27,"preClose":13.37,"latestTime":"17:56 EST","volume":3034,"amount":40460.75652,"timestamp":1770245810391,"change":-0.1,"changeRate":-0.007479,"amplitude":0.05834},"volumeRatio":1.145129},"requestUrl":"/m/hq/s/PLRZ","defaultTab":"news","newsList":[{"id":"2608582476","title":"Polyrizon Ltd.股价飙升12.25% 市值涨164.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608582476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608582476?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:35","pubTimestamp":1770042902,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日22时35分，Polyrizon Ltd.股票出现波动，股价急速上涨12.25%。截至发稿，该股报12.92美元/股，成交量1.5876万股，换手率1.52%，振幅4.17%。Polyrizon Ltd.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Polyrizon Ltd.、Verrica制药涨幅较大，60 Degrees Pharmaceuticals, Inc.、Vivosim Labs, Inc.、Vyome Holdings, Inc.较为活跃，换手率分别为248.27%、17.03%、14.96%，振幅较大的相关个股有Bioatla, Inc.、Context Therapeutics Inc.、天演药业，振幅分别为27.73%、18.39%、15.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202223502a6cab6b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202223502a6cab6b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRZ"],"gpt_icon":0},{"id":"1117300089","title":"Polyrizon启动Nasarix™过敏阻断剂可用性研究项目，推进监管审批进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1117300089","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117300089?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:27","pubTimestamp":1769092073,"startTime":"0","endTime":"0","summary":"Polyrizon有限公司在推进其主打产品Nasarix™过敏阻断剂的监管审批道路上迈出了关键一步，正式启动了该产品的可用性研究项目。这一举措旨在评估产品的实际使用体验与性能，为后续向监管机构提交申请收集必要的数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1108909694","title":"Polyrizon Ltd. 董事会批准进行选择性投资，预计将产生近期收益","url":"https://stock-news.laohu8.com/highlight/detail?id=1108909694","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108909694?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:46","pubTimestamp":1768311997,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 宣布，其董事会已正式批准一项战略计划，将着手进行一系列选择性投资。公司方面表示，这些经过精心筛选的投资项目，预计将在短期内为公司带来可观的收入增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1176001861","title":"Polyrizon Ltd. 初期战略聚焦高潜力领域运营公司，涵盖国防、航空及人工智能","url":"https://stock-news.laohu8.com/highlight/detail?id=1176001861","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176001861?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:44","pubTimestamp":1768311852,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 正将其初步发展重心，精准锁定于多个高增长潜力行业的运营公司。其战略布局尤其关注国防、航空以及人工智能等前沿领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1109995262","title":"Polyrizon 向 FDA 提交 PL-16 病毒阻断剂的前期指定请求，旨在减少对流感和感冒病毒的暴露","url":"https://stock-news.laohu8.com/highlight/detail?id=1109995262","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109995262?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:20","pubTimestamp":1766150456,"startTime":"0","endTime":"0","summary":"Polyrizon 向 FDA 提交 PL-16 病毒阻断剂的前期指定请求，旨在减少对流感和感冒病毒的暴露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1122590563","title":"Polyrizon宣布良好的渗透动力学，支持其鼻用纳洛酮水凝胶项目的推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1122590563","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122590563?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:15","pubTimestamp":1765458914,"startTime":"0","endTime":"0","summary":"Polyrizon宣布良好的渗透动力学，支持其鼻用纳洛酮水凝胶项目的推进","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1118176425","title":"Polyrizon发布与市场上市的鼻用纳洛酮产品相比的积极粘附性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1118176425","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118176425?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:29","pubTimestamp":1764772150,"startTime":"0","endTime":"0","summary":"Polyrizon发布与市场上市的鼻用纳洛酮产品相比的积极粘附性结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"1108302800","title":"Polyrizon宣布按1至6的比例进行普通股反向拆分 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1108302800","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108302800?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:05","pubTimestamp":1764075912,"startTime":"0","endTime":"0","summary":"Polyrizon宣布按1至6的比例进行普通股反向拆分 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2583063750","title":"Polyrizon Ltd.盘中异动 股价大跌6.41%报0.721美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583063750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583063750?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:30","pubTimestamp":1763130625,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时30分，Polyrizon Ltd.股票出现异动，股价快速下挫6.41%。截至发稿，该股报0.721美元/股，成交量2.8445万股，换手率0.47%，振幅2.47%。Polyrizon Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cidara Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.、Invivyd, Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为686.43%、33.92%、25.30%，振幅较大的相关个股有Silo Pharma, Inc.、Precigen, Inc.、Fennec Pharmaceuticals Inc.，振幅分别为9.19%、7.25%、7.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142230259504b00d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142230259504b00d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRZ"],"gpt_icon":0},{"id":"1106685558","title":"Polyrizon Ltd.公布积极的临床前研究结果：Pl-14显示出令人鼓舞的过敏原阻断效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1106685558","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106685558?lang=zh_cn&edition=full","pubTime":"2025-10-06 20:22","pubTimestamp":1759753369,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd.宣布其候选药物Pl-14在临床前研究中取得积极进展，该药物在过敏原阻断方面展现出令人鼓舞的疗效表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2558616820","title":"Polyrizon Ltd.8月11日成交额为76.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558616820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558616820?lang=zh_cn&edition=full","pubTime":"2025-08-12 13:22","pubTimestamp":1754976127,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Polyrizon Ltd.成交额为76.15万美元，成交额较昨日增加47.39%，当日成交量为74.94万股。Polyrizon Ltd.于2025年8月11日跌6.36%，报1.03美元，该股过去5个交易日跌13.45%，年初至今跌99.81%，过去60日跌68.31%。其技术平台有 Capture & Contain 和 Trap & Target。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812132208a6e0ee52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812132208a6e0ee52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRZ"],"gpt_icon":0},{"id":"2558065435","title":"Polyrizon Ltd.8月8日成交额为51.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558065435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558065435?lang=zh_cn&edition=full","pubTime":"2025-08-09 13:20","pubTimestamp":1754716851,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Polyrizon Ltd.成交额为51.66万美元，成交额较昨日减少29.01%，当日成交量为47.04万股。Polyrizon Ltd.于2025年8月8日跌5.17%，报1.1美元，该股过去5个交易日涨0.92%，年初至今跌99.8%，过去60日跌84.83%。其技术平台有 Capture & Contain 和 Trap & Target。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809132055a47e60ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809132055a47e60ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polyrizon-biotech.com","stockEarnings":[{"period":"1week","weight":0.0728},{"period":"1month","weight":0.2361},{"period":"3month","weight":1.7149},{"period":"6month","weight":1.2644},{"period":"1year","weight":-0.9915},{"period":"ytd","weight":0.8563}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Polyrizon Ltd.于2005年1月在以色列注册成立。该公司是一家处于发展阶段的生物技术公司，专门开发以鼻喷雾剂形式交付的创新医疗器械水凝胶，该水凝胶在鼻腔内形成一层薄薄的基于水凝胶的防护屏障，可以防止病毒和过敏原接触鼻上皮组织。该公司的C&C水凝胶技术由天然存在的构建块的混合物组成，以鼻喷雾剂的形式提供，并可用作“生物面具”，在鼻腔内有一层薄薄的防护屏障。该公司正在进一步开发其专有的C&C水凝胶技术的某些方面，例如生物粘附性和在鼻腔沉积部位的延长保留时间，以用于鼻内给药。该公司将其专注于API鼻腔给药的独立平台技术称为T&T。","exchange":"NASDAQ","name":"Polyrizon Ltd.","nameEN":"Polyrizon Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Polyrizon Ltd.,PLRZ,Polyrizon Ltd.股票,Polyrizon Ltd.股票老虎,Polyrizon Ltd.股票老虎国际,Polyrizon Ltd.行情,Polyrizon Ltd.股票行情,Polyrizon Ltd.股价,Polyrizon Ltd.股市,Polyrizon Ltd.股票价格,Polyrizon Ltd.股票交易,Polyrizon Ltd.股票购买,Polyrizon Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}